BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/15/2025 9:03:18 AM | Browse: 97 | Download: 303
 |
Received |
|
2025-06-03 13:21 |
|
Peer-Review Started |
|
2025-06-05 00:07 |
|
First Decision by Editorial Office Director |
|
2025-06-10 05:13 |
|
Return for Revision |
|
2025-06-10 05:13 |
|
Revised |
|
2025-06-21 03:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-08-08 01:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-22 09:02 |
|
Articles in Press |
|
2025-08-22 09:02 |
|
Edit the Manuscript by Language Editor |
|
2025-08-26 21:57 |
|
Typeset the Manuscript |
|
2025-10-10 05:40 |
|
Publish the Manuscript Online |
|
2025-10-15 09:03 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Association between antidiabetic drugs and cancer risk in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xue-Dong An, Li-Yun Duan, Yue-Hong Zhang, Qian-You Jia, Yan-Min Zhang and Yun Qiao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82305205 |
| Young Elite Scientists Sponsorship Program by China Association of Chinese Medicine |
2023-QNRC2-A05 |
| Safeguard Project of Guang’anmen Hospital, China Academy of Chinese Medical Sciences |
GAMHH9324001 |
| Special Program for the Training of Outstanding Young Scientific and Technological Talents Under the Basic Scientific Research Operating Expenses of the China Academy of Chinese Medical Sciences |
ZZ18-YQ-011 |
|
| Corresponding Author |
Yun Qiao, Department of Traditional Chinese Medicine, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan 250012, Shandong Province, China. qiaoyun@qiluhospital.com |
| Key Words |
Antidiabetic drugs; Type 2 diabetes mellitus; Cancer; Systematic review; Network meta-analysis |
| Core Tip |
Studies have shown that diabetes itself is associated with an increased risk of various cancers. Relevant research indicates that commonly used antidiabetic drugs have varying impacts on cancer risk - some provide protective effects, while others may increase the risk in specific populations. We conducted a network meta-analysis to compare the effects of different antidiabetic drugs on the risk of various cancers in patients with type 2 diabetes mellitus. |
| Publish Date |
2025-10-15 09:03 |
| Citation |
An XD, Duan LY, Zhang YH, Jia QY, Zhang YM, Qiao Y. Association between antidiabetic drugs and cancer risk in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis. World J Diabetes 2025; 16(10): 110174 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i10/110174.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i10.110174 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
